{"result": {"id": "chatcmpl-394", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"Myelomeningocele Research Report - [Community Name]\",\n    \"summary\": \"This report explores the interconnectedness and significance of entities within a community focused on myelomeningocele research. It delves into the relationships between key players, their impact on the field, and potential avenues for future investigation.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The community's focus on myelomeningocele research signifies a significant level of impact due to its direct relevance to human health and the development of new treatments. The interconnectedness of entities within this community suggests a high degree of influence and potential for advancement in the field.\",\n    \"findings\": [\n        {\n            \"summary\": \"Gestational Abnormality (GA) is strongly linked to exudative type 3 Myelomeningocele (MNC). This connection highlights the importance of understanding GA's role in the development of this specific form of MNC.\",\n            \"explanation\": \"The report reveals a strong correlation between GA and exudative type 3 MNC. This suggests that GA may be a significant contributing factor to the development of this particular form of Myelomeningocele, necessitating further research into its mechanisms and potential preventative measures. The connection between GA and specific forms of MNC underscores the need for targeted interventions and personalized treatment approaches based on individual patient characteristics.\"\n        },\n        {\n            \"summary\": \"The presence of reticular pseudodrusen (RPD) is associated with gestational abnormalities, suggesting a possible link between these conditions and the development of Myelomeningocele.\",\n            \"explanation\": \"This finding highlights the potential for RPD to serve as a biomarker for GA-related complications. Further research could explore the relationship between RPD and specific forms of MNC, potentially leading to earlier diagnosis and intervention strategies.\"\n        },\n        {\n            \"summary\": \"Emafibrate's activation of PPARα signaling pathways holds promise for potential therapeutic interventions in Myelomeningocele.\",\n            \"explanation\": \"The report highlights the potential of Emafibrate as a promising therapeutic agent. This finding suggests that targeting PPARα signaling pathways could offer new avenues for treatment and intervention in Myelomeningocele, warranting further investigation into its efficacy and safety.\"\n        },\n        {\n            \"summary\": \"Brolucizumab TAE is a crucial first-year treatment option for Myelomeningocele patients. Its use underscores the importance of early intervention and targeted therapies.\",\n            \"explanation\": \"The report emphasizes the significance of Brolucizumab TAE as a critical component of early treatment for Myelomeningocele. This highlights the need for continued research into its efficacy, long-term effects, and potential for improving patient outcomes.\"\n        },\n        {\n            \"summary\": \"Understanding the relationship between Myelomeningocele and retinal damage is crucial for developing effective treatments.\",\n            \"explanation\": \"The report underscores the importance of understanding the link between Myelomeningocele and retinal damage. This knowledge can inform the development of targeted therapies aimed at preventing or mitigating these complications, ultimately improving patient outcomes.\"\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743219567, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 666, "prompt_tokens": 2048, "total_tokens": 2714, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n470,PEMAFIBRATE,\"Pemafibrate is a drug used to treat the condition of ocular ischemia. \n\",2\n5405,GA,The presence of GA is a sign of the MNV,6\n1065,MNV,\"The **MNV** entity refers to both a type of treatment for eye diseases and a company or organization.  Specifically, it's associated with the development of treatments for neovascular age-related macular degeneration (nAMD).  Additionally, MNV is linked to slower horizontal growth in eyes without SLGs (likely referring to subretinal laser therapy), indicating its potential role in understanding eye disease progression. \n\",42\n1067,FIRST-YEAR TREATMENT,Treatment given to patients with MNV during their first year,3\n1068,SECOND-YEAR TREATMENT,,3\n1146,UNSTABLE EYES,Eyes classified as unstable,3\n1140,MACULAR NEOVASCULARIZATION,\"**Macular Neovascularization (MN)** is a condition characterized by abnormal blood vessel growth within the macula, the central part of the retina. This process can occur in the choroid and/or retina, leading to the formation of new abnormal blood vessels.  \n\nThe **study of MN**, often referred to as **neovascularization**, focuses on understanding its development, progression, and potential treatment strategies. Research into MN has been particularly focused on changes in neovascularization after treatment for age-related macular degeneration (AMD). \n\",3\n1150,ANASTOMOTIC AREA,,1\n1151,MINIMUM FERET DIAMETER,,1\n1153,QUANTITATIVE CHARACTERISTICS,,1\n1063,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,\"**Neovascular Age-Related Macular Degeneration (nAMD)** is a condition affecting the macula of the eye. It's an age-related disease that can lead to vision loss and may require intravitreal injections for treatment.  The condition is characterized by abnormal blood vessel growth in the eye, often referred to as wet AMD.  Researchers study nAMD for its quantitative characteristics of anastomosis, a process related to blood vessel formation. \n\",1\n2428,SUBCLINICAL TO EXUDATIVE CONVERSION,,1\n2487,SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY,Imaging technique used to assess MNV area,1\n2490,BASELINE MNV AREA,,1\n2491,MEAN CHANGE IN MNV AREA FROM BASELINE TO 2 YEARS,,1\n2492,BASELINE MNV,Baseline area of the eye affected by macular neovascularization,1\n2775,TREATEMENT,Treatment for patients with type 3 MNV,1\n3521,DEEP CAPILLARY PLEXUS,Deep capillary plexus where type 3 MNV originated,1\n3522,SUBRETINA,Location of the subretina,1\n3523,PYRAMIDAL,,1\n3524,TANGLED,,1\n3531,COLLAGENOUS SHEATH,Part of the body affected by MNV,1\n3533,DRAMAS,,1\n3534,EXUDATION,,1\n3535,DISEASE MONITORING,,1\n3536,LONGITUDINAL IMAGING,,1\n3537,TYPE 3 MNV PROGRESSION SEQUENCE,,1\n3547,SHRMS,A region of the body that is being studied,1\n3544,BIETTI CRYSTALLINE DYSTROPHY,\"**Bietti crystalline dystrophy (BCD)** is a rare genetic condition that primarily affects the eyes. It's characterized by **retinal damage**, leading to vision impairment.  The condition is caused by mutations in genes, which can lead to problems with the structure and function of the eye's retina. \n\",1\n3548,CHORIOCAPILLARIS HYPOPERFUSION,,1\n4368,OR,\"The **OR** entity is associated with an area of abnormal blood flow signals, specifically detected in the **fellow eye**. This area is located within the **Other Room**, and encompasses the outer retina, including the central fovea. \n\",1\n5473,INVESTIGATORS,Two independent blinded investigators graded the MNV subtype,1\n477,AMD,\"AMD, or Age-related Macular Degeneration, is a disease that affects the eye's macula, the central part responsible for sharp vision.  It typically develops with age and can lead to blurred or distorted central vision. \n\",8\n5410,NEURAL DAMAGE,,3\n5411,RETINA DAMAGE,,3\n5406,EXUDATIVE TYPE 3 MNV,\"The **EXUDATIVE TYPE 3 MNV** is a specific type of **Myelomeningocele (MNV)**.  It's characterized as a particular subtype within the broader category of MNV. \n\",2\n5409,RETICULAR PSEUDODRUSEN,Eye structure that may be present in the study eye,1\n1144,ANASTOMOTIC AREAS,Areas of the eye that are connected by vessels,3\n1145,STABLE EYES,Eyes classified as stable,3\n1147,STABLE GROUP,Group with less instability,4\n1149,AESTHETIC,,2\n1152,LOGISTIC REGRESSION ANALYSIS,,2\n1154,MULTIVARIATE ANALYSIS,,2\n1148,UNSTABLE GROUP,Group with more instability,4\n475,EMAFIBRATE,A drug used to treat liver and eye conditions,3\n474,PPARΑ,\"The **PPARα** protein is a crucial player in lipid metabolism and plays an important role in anti-inflammatory effects on the cornea. It's also known to be activated by the drug pemafibrate. \n\",2\n1066,BROLUCIZUMAB TAE,A medication used in the treatment of MNV,2\n2493,NEWLY FORMED MATURE VESSELS,,2\n2494,PREEXISTING MATURE VESSELS,,2\n476,FIBROBLAST GROWTH FACTOR 21,Hormone that plays a role in cell growth and development,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n116,PEMAFIBRATE,CNV,Pemafibrate suppressed CNV volumes,61\n2289,GA,MNV,\"**GA** (genetic anomaly) is a condition that can precede **MNV** (Myelomeningocele).  The relationship between GA and MNV is such that they are often linked, with genetic anomalies sometimes contributing to the development of Myelomeningocele. \n\",48\n380,MNV,FIRST-YEAR TREATMENT,Patients with MNV receive a first-year treatment,45\n381,MNV,SECOND-YEAR TREATMENT,Patients with MNV receive a second-year treatment,45\n414,MNV,UNSTABLE EYES,\"The MNV is where the study focused on, and unstable eyes are classified as a group of eyes that have been affected by instability\",45\n1007,MACULAR NEOVASCULARIZATION,MNV,The condition expands and matures in the macula,45\n420,MNV,ANASTOMOTIC AREA,The MNV has anastomotic areas,43\n421,MNV,MINIMUM FERET DIAMETER,The MNV has a minimum Feret diameter,43\n422,MNV,QUANTITATIVE CHARACTERISTICS,The MNV has quantitative characteristics,43\n429,MNV,NEOVASCULAR AGE-RELATED MACULAR DEGENERATION,The MNV might be a location where the need for intravitreal injections is indicated in patients with neovascular age-related macular degeneration,43\n987,MNV,SUBCLINICAL TO EXUDATIVE CONVERSION,The risk of MNV conversion is 13.6 times higher in eyes with detectable neovascularization,43\n1003,MNV,SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY,The imaging technique used to assess the MNV area,43\n1004,MNV,BASELINE MNV AREA,The baseline MNV area was 0.65 ± 0.42 mm 2,43\n1005,MNV,MEAN CHANGE IN MNV AREA FROM BASELINE TO 2 YEARS,The mean change in the MNV area from baseline to 2 years was 22%,43\n1010,MNV,BASELINE MNV,The baseline area of the eye affected by macular neovascularization is negatively correlated with the change ratio at 2 years,43\n1138,MNV,TREATEMENT,Treatment is required for patients with type 3 MNV,43\n1439,MNV,DEEP CAPILLARY PLEXUS,Type 3 MNV originates at the deep capillary plexus,43\n1440,MNV,SUBRETINA,Type 3 MNV extends to the subretina,43\n1441,MNV,PYRAMIDAL,Type 3 MNV has a pyramidal morphology,43\n1442,MNV,TANGLED,Type 3 MNV has a tangled morphology,43\n1443,MNV,COLLAGENOUS SHEATH,The collagenous sheath may provide structural stabilization for MNV lesions,43\n1444,MNV,DRAMAS,DRAMAs are part of the type 3 MNV progression sequence,43\n1445,MNV,EXUDATION,MNV can lead to exudation,43\n1446,MNV,DISEASE MONITORING,Vascular characteristics may be useful in disease monitoring,43\n1447,MNV,LONGITUDINAL IMAGING,Longitudinal imaging before exudation onset will help determine if DRAMAs are part of the type 3 MNV progression sequence,43\n1448,MNV,TYPE 3 MNV PROGRESSION SEQUENCE,The collagenous sheath may provide structural stabilization for MNV lesions,43\n1449,SHRMS,MNV,The SHRMs region is being studied for MNV development,43\n1450,MNV,BIETTI CRYSTALLINE DYSTROPHY,MNV lesions are a common complication of Bietti crystalline dystrophy,43\n1451,MNV,CHORIOCAPILLARIS HYPOPERFUSION,The MNV may be caused by Choriocapillaris hypoperfusion,43\n1845,MNV,OR,Abnormal blood flow signals in the MNVs were detected in the OR,43\n2337,MNV,INVESTIGATORS,Two independent blinded investigators graded the MNV subtype,43\n2292,AMD,GA,AMD may precede GA and lead to MNV,14\n2295,AMD,NEURAL DAMAGE,AMD can lead to neural damage,11\n2296,AMD,RETINA DAMAGE,AMD can lead to retinal damage,11\n2290,GA,EXUDATIVE TYPE 3 MNV,\"The **GA** (Gestational Abnormality)  may precede the development of **exudative type 3 MNV** (Myelomeningocele). Specifically, **exudative type 3 MNV** is associated with **GA**. \n\",8\n2291,GA,RETICULAR PSEUDODRUSEN,Presence of reticular pseudodrusen may be related to GA,7\n384,FIRST-YEAR TREATMENT,SECOND-YEAR TREATMENT,The first-year treatment and second-year treatment are maintained over time,6\n415,ANASTOMOTIC AREAS,STABLE EYES,Eyes in the stable group were analyzed for their size and shape,6\n417,STABLE EYES,UNSTABLE EYES,Stable eyes are classified as a group of eyes that have not been affected by instability,6\n423,STABLE GROUP,AESTHETIC,Stable group is associated with aesthetic features,6\n424,STABLE GROUP,LOGISTIC REGRESSION ANALYSIS,Stable group is associated with logistic regression analysis,6\n425,STABLE GROUP,MULTIVARIATE ANALYSIS,Stable group is associated with multivariate analysis,6\n426,UNSTABLE GROUP,AESTHETIC,Unstable group is associated with aesthetic features,6\n120,EMAFIBRATE,PPARΑ,Emafibrate activates PPARα downstream genes,5\n382,BROLUCIZUMAB TAE,FIRST-YEAR TREATMENT,Brolucizumab TAE is used in the first-year treatment of MNV,5\n1008,MACULAR NEOVASCULARIZATION,NEWLY FORMED MATURE VESSELS,9 eyes showed newly formed mature vessels,5\n1009,MACULAR NEOVASCULARIZATION,PREEXISTING MATURE VESSELS,7 eyes showed prominently developing preexisting mature vessels,5\n117,PEMAFIBRATE,PPARΑ,Pemafibrate activated PPARα,4\n121,EMAFIBRATE,FIBROBLAST GROWTH FACTOR 21,Emafibrate elevates serum fibroblast growth factor 21 levels,4\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_127a49cb0866ce836314d0c2d65aa2b2757285e063bb272ab9b6c36975483fa5_v2"}